(RTTNews) - Corvus Pharmaceuticals, Inc.(CRVS), a clinical-stage biopharmaceutical company, Thursday reported positive data from its Phase 1/1b study of soquelitinib for the treatment of patients ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
CHARLOTTE, N.C. - March 13, 2025 - Honeywell has announced its SwiftDecoder barcode-decoding software will be integrated into Corvus Robotics’ self-flying inventory drones. This pioneering solution ...
March 12, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the National Institute of Allergy and Infectious ...
KZR Kezar Life Sciences, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback